Several members of the group and our collaborators published an article in Nature Medicine where we modeled shield immunity. With shield immunity, Covid-19 recovered individuals (with antibodies against Covid-19) could be deployed as focal points for safer interactions with sensitive populations. A shield immunity dashboard is in progress and will be forthcoming in January 2021.